Drug information for ASPIRIN AND DIPYRIDAMOLE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE, EXTENDED RELEASE; ORAL 25MG;200MG Prescription AB  ASPIRIN; DIPYRIDAMOLE aspirin, dipyridamole drug combination BARR 78804
2009-08-21 Letter

Drug Adverse Effects information for ASPIRIN AND DIPYRIDAMOLE

Role code Indications Reaction # Reports
SS ATRIAL FLUTTER DUODENAL ULCER 1
SS ATRIAL FLUTTER HAEMOGLOBIN DECREASED 1
SS ATRIAL FLUTTER MELAENA 1
SS ATRIAL FLUTTER PLATELET COUNT INCREASED 1
SS BLOOD HOMOCYSTEINE INCREASED DUODENAL ULCER 1
SS BLOOD HOMOCYSTEINE INCREASED HAEMOGLOBIN DECREASED 1
SS BLOOD HOMOCYSTEINE INCREASED MELAENA 1
SS BLOOD HOMOCYSTEINE INCREASED PLATELET COUNT INCREASED 1
SS CEREBROVASCULAR ACCIDENT GASTRIC HAEMORRHAGE 1
SS DUODENAL ULCER DUODENAL ULCER 1
SS DUODENAL ULCER HAEMOGLOBIN DECREASED 1
SS DUODENAL ULCER MELAENA 1
SS DUODENAL ULCER PLATELET COUNT INCREASED 1
SS PAIN DUODENAL ULCER 1
SS PAIN GASTRIC HAEMORRHAGE 1
SS PAIN HAEMOGLOBIN DECREASED 1
SS PAIN MELAENA 1
SS PAIN PLATELET COUNT INCREASED 1
SS PROPHYLAXIS DUODENAL ULCER 1
SS PROPHYLAXIS GASTRIC HAEMORRHAGE 1
SS PROPHYLAXIS HAEMOGLOBIN DECREASED 1
SS PROPHYLAXIS MELAENA 1
SS PROPHYLAXIS PLATELET COUNT INCREASED 1
C BLOOD FOLATE DECREASED CEREBROVASCULAR ACCIDENT 1
C CHRONIC MYELOID LEUKAEMIA ACUTE MYOCARDIAL INFARCTION 1
C CHRONIC MYELOID LEUKAEMIA ANGINA PECTORIS 1
C CHRONIC MYELOID LEUKAEMIA CHEST DISCOMFORT 1
C CHRONIC MYELOID LEUKAEMIA CHEST PAIN 1
C CHRONIC MYELOID LEUKAEMIA DYSPNOEA EXERTIONAL 1
C CHRONIC MYELOID LEUKAEMIA FATIGUE 1
C CHRONIC MYELOID LEUKAEMIA LIMB DISCOMFORT 1
C CHRONIC MYELOID LEUKAEMIA MUSCULOSKELETAL PAIN 1
C CHRONIC MYELOID LEUKAEMIA MYOCARDIAL ISCHAEMIA 1
C CHRONIC MYELOID LEUKAEMIA PERIPHERAL VASCULAR DISORDER 1
C DIABETES MELLITUS DRUG INTERACTION 3
C DIABETES MELLITUS FALL 3
C DIABETES MELLITUS NAUSEA 3
C DIABETES MELLITUS OEDEMA 3
C DIABETES MELLITUS VOMITING 3
C DIABETES MELLITUS WEIGHT DECREASED 3
C DYSPEPSIA CEREBROVASCULAR ACCIDENT 1
C HYPERTENSION CEREBROVASCULAR ACCIDENT 2
C IRON DEFICIENCY DRUG INTERACTION 2
C IRON DEFICIENCY FALL 2
C IRON DEFICIENCY NAUSEA 2
C IRON DEFICIENCY OEDEMA 2
C IRON DEFICIENCY VOMITING 2
C IRON DEFICIENCY WEIGHT DECREASED 2
C MACULAR DEGENERATION CEREBROVASCULAR ACCIDENT 1
C PARKINSON'S DISEASE DRUG INTERACTION 13
C PARKINSON'S DISEASE FALL 13
C PARKINSON'S DISEASE NAUSEA 13
C PARKINSON'S DISEASE OEDEMA 13
C PARKINSON'S DISEASE VOMITING 13
C PARKINSON'S DISEASE WEIGHT DECREASED 13
C PERNICIOUS ANAEMIA DRUG INTERACTION 3
C PERNICIOUS ANAEMIA FALL 3
C PERNICIOUS ANAEMIA NAUSEA 3
C PERNICIOUS ANAEMIA OEDEMA 3
C PERNICIOUS ANAEMIA VOMITING 3
C PERNICIOUS ANAEMIA WEIGHT DECREASED 3
C PRODUCT USED FOR UNKNOWN INDICATION CEREBROVASCULAR ACCIDENT 1
C PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 1
C PRODUCT USED FOR UNKNOWN INDICATION FALL 1
C PRODUCT USED FOR UNKNOWN INDICATION NAUSEA 1
C PRODUCT USED FOR UNKNOWN INDICATION OEDEMA 1
C PRODUCT USED FOR UNKNOWN INDICATION VOMITING 1
C PRODUCT USED FOR UNKNOWN INDICATION WEIGHT DECREASED 1
C TRANSIENT ISCHAEMIC ATTACK CEREBROVASCULAR ACCIDENT 2
C TYPE 2 DIABETES MELLITUS URTICARIA 2
C TYPE 2 DIABETES MELLITUS VOMITING 2
Ads by Google